ANGN insider filings
Angion Biomedica Corp. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-07-11. Screen ANGN transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ANGN between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Angion Biomedica Corp.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2022-07-11 | 4 | Goldberg Itzhak — Director | Tax withholding (F): 32,082 @ $1.12 | EDGAR |
| 2022-06-13 | 4 | Nissenson Allen — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | WILSON KAREN J — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | GANZI VICTOR F — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | OMENN GILBERT S — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-05-27 | 4 | Venkatesan Jay — See Remarks, Director | Purchase (P): 11,313 @ $1.25 | EDGAR |
| 2022-05-27 | 4/A | Venkatesan Jay — See Remarks, Director | Option exercise/expiry (X): 396,329 @ $6.43 · Sale (S): 159,177 @ $16 · Conversion (C): 262 @ $11.57 · Option exercise/expiry (X): 396,329 (derivative) @ $0 | EDGAR |
| 2022-05-27 | 4/A | GANZI VICTOR F — Director | Option exercise/expiry (X): 614,310 @ $6.43 · Sale (S): 246,720 @ $16 · Option exercise/expiry (X): 614,310 (derivative) @ $0 | EDGAR |
| 2022-05-25 | 4 | Venkatesan Jay — See Remarks, Director | Purchase (P): 50,000 @ $1.23 · Purchase (P): 32,200 @ $1.24 | EDGAR |
| 2022-05-23 | 4 | Nissenson Allen — Director | Purchase (P): 7,346 @ $1.16 · Purchase (P): 2,037 @ $1.18 | EDGAR |
| 2022-03-04 | 4 | Neylan John F. — See Remarks | Grant/award (A): 175,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-03-04 | 4 | Rhodes Jennifer J — See Remarks | Grant/award (A): 175,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-03-04 | 4 | Venkatesan Jay — See Remarks | Grant/award (A): 600,000 (derivative) @ $0 · Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2022-03-04 | 4 | CURHAN GREGORY S — See Remarks | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-12-29 | 4 | Venkatesan Jay — See Remarks, Director | Purchase (P): 66,907 @ $2.55 · Purchase (P): 210,337 @ $2.66 | EDGAR |
| 2021-12-22 | 4 | Venkatesan Jay — See Remarks, Director | Purchase (P): 3,527 @ $2.54 | EDGAR |
| 2021-12-21 | 4 | Neylan John F. — See Remarks | Sale (S): 358 @ $2.62 | EDGAR |
| 2021-12-20 | 4 | Venkatesan Jay — See Remarks, Director | Purchase (P): 27,883 @ $2.55 · Purchase (P): 13,742 @ $2.54 | EDGAR |
| 2021-12-17 | 4 | Venkatesan Jay — See Remarks, Director | Tax withholding (F): 41,091 @ $13.78 · Purchase (P): 77,604 @ $2.41 | EDGAR |
| 2021-12-16 | 4 | CURHAN GREGORY S — See Remarks | Purchase (P): 4,000 @ $2.37 | EDGAR |
| 2021-12-15 | 4 | Rhodes Jennifer J — See Remarks | Sale (S): 451 @ $2.42 | EDGAR |
| 2021-12-07 | 4 | Goldberg Itzhak — See Remarks, Director | Sale (S): 32,118 @ $3.35 | EDGAR |
| 2021-12-03 | 4 | Goldberg Itzhak — See Remarks, Director | Sale (S): 38,867 @ $3.54 · Sale (S): 38,800 @ $3.51 · Sale (S): 40,215 @ $3.39 | EDGAR |
| 2021-11-22 | 4 | Neylan John F. — See Remarks | Sale (S): 374 @ $4.13 | EDGAR |
| 2021-11-17 | 4 | Goldberg Itzhak — See Remarks | Tax withholding (F): 47,410 @ $13.78 · Sale (S): 111,505 @ $4.17 · Sale (S): 38,495 @ $4.26 | EDGAR |
| 2021-11-16 | 4 | Rhodes Jennifer J — See Remarks | Sale (S): 433 @ $4.40 | EDGAR |
| 2021-10-20 | 4 | Neylan John F. — See Remarks | Sale (S): 373 @ $8.62 | EDGAR |
| 2021-10-15 | 4 | Rhodes Jennifer J — See Remarks | Sale (S): 430 @ $8.65 | EDGAR |
| 2021-09-21 | 4 | Neylan John F. — See Remarks | Sale (S): 376 @ $10.07 | EDGAR |
| 2021-09-15 | 4 | Rhodes Jennifer J — See Remarks | Sale (S): 430 @ $10.64 | EDGAR |
| 2021-08-31 | 4 | EISA-ABC LLC — 10% owner | Other (J): 913,659 @ $0 | EDGAR |
| 2021-08-19 | 4 | Neylan John F. — See Remarks | Sale (S): 381 @ $9.03 | EDGAR |
| 2021-08-17 | 4 | Rhodes Jennifer J — See Remarks | Sale (S): 445 @ $10.68 | EDGAR |
| 2021-07-22 | 4 | Neylan John F. — See Remarks | Sale (S): 365 @ $10.98 | EDGAR |
| 2021-07-22 | 4 | Rhodes Jennifer J — See Remarks | Sale (S): 432 @ $10.94 | EDGAR |
| 2021-07-20 | 4/A | Rhodes Jennifer J — See Remarks | Holdings only — no transactions reported | EDGAR |
| 2021-07-15 | 4 | Rhodes Jennifer J — See Remarks | Sale (S): 431 @ $11.01 | EDGAR |
| 2021-06-21 | 4 | Neylan John F. — See Remarks | Sale (S): 366 @ $13.20 | EDGAR |
| 2021-06-16 | 4 | Rhodes Jennifer J — See Remarks | Sale (S): 427 @ $13.27 | EDGAR |
| 2021-05-19 | 4 | Neylan John F. — See Remarks | Sale (S): 363 @ $13.91 | EDGAR |
| 2021-05-18 | 4 | Rhodes Jennifer J — See Remarks | Sale (S): 440 @ $13.92 | EDGAR |
| 2021-04-20 | 4 | Neylan John F. — See Remarks | Sale (S): 381 @ $13.55 | EDGAR |
| 2021-04-15 | 4 | Rhodes Jennifer J — See Remarks | Sale (S): 399 @ $15.01 | EDGAR |
| 2021-03-19 | 4 | Neylan John F. — See Remarks | Sale (S): 442 @ $19.13 | EDGAR |
| 2021-03-16 | 4 | Rhodes Jennifer J — See Remarks | Sale (S): 499 @ $20.45 | EDGAR |
| 2021-03-10 | 4 | WILSON KAREN J — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-03-10 | 4 | GANZI VICTOR F — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-03-10 | 4 | OMENN GILBERT S — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-02-17 | 4 | Rhodes Jennifer J — See Remarks | Sale (S): 457 @ $19.54 | EDGAR |
| 2021-02-11 | 4 | OMENN GILBERT S — Director | Conversion (C): 23,483 @ $11.57 · Conversion (C): 23,391 @ $11.57 · Conversion (C): 14,783 @ $11.57 · Conversion (C) @ $0 · Conversion (C) @ $0 · Conversion (C) @ $0 | EDGAR |
Recent 8-K events — Angion Biomedica Corp.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-13 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-11-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-14 | 8-K | ? 8.01 — Other Events | EDGAR |
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-24 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-06-17 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-06-15 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-16 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ANGN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs